BDTX FY 2023 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$126M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$437,000

Operating Income

-$86M

Net Income

-$82M

EPS (Diluted)

$-1.88

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$67M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$159M

Total Liabilities

$42M

Stockholders' Equity

$117M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$437,000	$0	—
Operating Income	-$86M	-$93M	+6.9%
Net Income	-$82M	-$91M	+9.6%